New research at Rhode Island Hospital has uncovered the biological effects of a novel membrane estrogen receptor, a finding that has potential implications for hormonal therapy for breast cancer. The study is published in the July edition of the journal Molecular Endocrinology. This new study by Edward Filardo, MD, and his research team further supports earlier published work by the group that linked the transmembrane receptor, GPR30/GPER-1, to specific estrogen binding, rapid estrogen signaling and breast cancer metastasis.
Full article >>
Wednesday, July 1, 2009
Newly appreciated membrane estrogen receptor important therapeutic target for breast cancer
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment